黄金城集团

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.

Cell Oncol (Dordr). 2018-08; 
Balcik-ErcinPelin,CetinMetin,Yalim-CamciIrem,OdabasGorkem,TokayNurettin,SayanA Emre,YagciT
Products/Services Used Details Operation
… The following antibodies were used: anti-ZEB2 (home- made monoclonal antibody, clone 6E5) [7], anti-ACTB mouse monoclonal antibody (A00702) from GenScript (Piscataway, NJ, USA), rabbit polyclonal anti-GALNT3 antibody (LS-C166355) from LifeSpan BioSciences …

摘要

ZEB2 is a transcriptional repressor that regulates epithelial-to-mesenchymal transition (EMT) through binding to bipartite E-box motifs in gene regulatory regions. Despite the abundant presence of E-boxes within the human genome and the multiplicity of pathophysiological processes regulated during ZEB2-induced EMT, only a small fraction of ZEB2 targets has been identified so far. Hence, we explored genome-wide ZEB2 binding by chromatin immunoprecipitation-sequencing (ChIP-seq) under endogenous ZEB2 expression conditions.

关键词

Antibody validation,ChIP-sequencing,GALNT3,Gene regulation,Tissue expression,